Schumer Warns of ‘Skin-Rotting Zombie Drug’ Gaining Popularity in New York

Chuck Schumer, the majority leader of the Senate, issued a warning to his components in New York about the new medication that he claims was make people’s skin perish.

Schumer said during a news conference on Sunday in Manhattan,” We all know what scum methadone has been throughout the New York area— New York City, Long Island, all the neighbourhoods— but now we’re witnessing an even worse type of drug being mixed with it.”

Schumer forewarned that users of this latest drug, xylazine,” could be a nightmare” because it is being combined with other addicting street drugs like heroin.

Bad drug dealers are now combining it with fentanyl, heroin, and other drugs to create a deadly, skin-rotting zombie drug, Schumer continued. And it’s on its way to New York City and Long Island, where we’ve already seen it start to rear its ugly head, bringing with it a horrifying flood of loss and abuse to the eastern of North York.

Describe Xylazine.

A non-opioid pharmacy sedative and pain reliever called Xylazine is frequently used in clinical settings. In addition to being used in clinical medicine, xylazine has also been used as a recreational pill, either by itself or in conjunction with other drugs like cocaine and fentanyl.

The National Institute on Drug Abuse( NIDA ) reports that xylazine use on a regular basis is also linked to skin abscesses, skin ulcers, and other complications. The loss of skin and tissue tissue, or necrosis, may result from these skin conditions.

Additionally, Xylazine has a special risk of abuse fatalities.

Naloxone has gained popularity as a means of lessening the effects of cocaine and methadone overdose on opioids. Meanwhile, xylazine, which is not an opiate, is ineffective against naloxone.

Naloxone does not address the impact of xylazine on ventilation because it is not an opiate, according to NIDA in a point sail on the rising use of the drug. ” Analysts are concerned that this may make naloxone less practical for some overdose due to a rising prevalence of xylazine in the illegal opioid supply.”

Alarm Is Rising Against Drug

In a new safety advisory released last week, the U.S. Drug Enforcement Administration ( DEA ) cautioned against the rising use of xylazine in drug mixtures.

According to DEA administrator Anne Milgram,” Xylazine is making fentanyl, the deadliest drug threat our nation has ever faced, sometimes deadlier.” In 48 of 50 States, xylazine and methadone combinations have been seized by DEA. According to the DEA Laboratory System, xylazine was present in about 23 % of fentanyl powder and 7 % of the pills seized by the agency in 2022.

The DEA claims that the Sinaloa and Jalisco organizations in Mexico are in charge of the vast majority of fentanyl that is trafficked in American communities. Additionally, according to the DEA, these organizations obtain a large portion of these molecular compounds from China.

According to Schumer,” Xylazine is” entering the nation through China and frequently through Mexico. Because it mimics drugs, especially these drug traffickers have begun to sell this medication.

Schumer also brought up the possibility of xylazine entering the illegal drug trade from legal animal pharmaceutical use. To find out how the medication might be moving from legal animal use to the illicit trade, the senator requested that the DEA send a diversion control team.

The New York Post reported last week that during a police raid on an accused person of money laundering in Queens, officers discovered more than 44 pounds of fentanyl cut with xylazine, according to Bridget Brennan, unique cocaine counsel for the community.

In the northeastern region of the United States, xylazine has become especially common in the illegal narcotic trade. In Pennsylvania, xylazine was found in 26 % of overdose deaths in 2020, up from just 2 percent in the entire state in 2015. In Maryland in 2021, xylazine was found in 19 % of all drug overdose fatalities, and in Connecticut in 2020, in 10 % of such incidents.

NTD News